Too much disclosure of product risks? CBC television, SOGC, and Diane-35

J Obstet Gynaecol Can. 2003 Apr;25(4):268-9; discussion 270-3. doi: 10.1016/s1701-2163(16)31028-3.
No abstract available

MeSH terms

  • Acne Vulgaris / drug therapy
  • Advertising*
  • Androgen Antagonists / adverse effects*
  • Androgen Antagonists / therapeutic use
  • Canada
  • Cyproterone Acetate / adverse effects*
  • Cyproterone Acetate / therapeutic use
  • Disclosure
  • Drug Combinations
  • Ethinyl Estradiol / adverse effects*
  • Ethinyl Estradiol / therapeutic use
  • Female
  • Humans
  • Odds Ratio
  • Risk Factors
  • United States
  • Venous Thrombosis / chemically induced*

Substances

  • Androgen Antagonists
  • Drug Combinations
  • Ethinyl Estradiol
  • Cyproterone Acetate
  • Cyproterone acetate, ethinyl estradiol drug combination